Voice your opinion on congressional bill S1250-118 and let lawmakers know your stance with UnPac!

Main Subject: Health

Drug-price Transparency for Consumers Act of 2023 or the DTC Act of 2023

This bill requires consumer advertisements for drugs and biologicals to include certain price information if the drug or biological is (1) covered under Medicare or Medicaid, and (2) required to include a risk summary under current law. The requirement does not apply to advertisements for drugs or biologicals with a wholesale cost of less than $35 for a one-month supply.

Each violation of this requirement is subject to a civil penalty of not more than $100,000.

Senate Actions

IntroReferral
Apr. 20 2023	Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S1297; text: CR S1297-1298)

Library of Congress Actions

IntroReferral
Apr. 20 2023	Introduced in Senate

Senate bill S1250-118

Drug-price Transparency for Consumers Act of 2023

Promote the cause!

Or use this QR code